Generics 20

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Aztreonam manufacturers

20 products found

Filters

20 products found

aztreonam

Powder for solution for injection 1 g, 2 g

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
FDA, EU GMP
Unavailable markets
Greece
Comments
Dossier status : Early stage
Manufacturer #313

A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, and Asia for 10+ years. Key production lines are Rx, OTC, and nutraceuticals. Main therapeutic areas include the respiratory system, dermatology, and cardiovascular system. The company possesses several branches in LATAM

Manufacturer usually replies in 7 days

aztreonam

Vials, lyophilized injection 250 mg, 500 mg, 1 g, 2 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 7 days

aztreonam

Injection 1 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20700

Manufacturer usually replies in 5 days

aztreonam

Powder for solution for injection 250 mg, 500 mg, 1000 mg, 2000 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17903
The company was founded in the 1990s. They manufacture generic pharmaceutical products, supplying the public and private institutions through bidding and direct sales. They manufacture and market more than 50 medicines, assuming the commitments of excellence, traceability, and quality.

Manufacturer usually replies in 1 days

aztreonam

Injection 1g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
WHO
Manufacturer #1027

Manufacturer usually replies in 4 days

aztreonam + l-arginine

Powder for solution for injection 1 g + 780 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #17267
Around 95 years ago the idea of the company was to build a pharmaceutical industry specializing in hospital medicines. The intention was to meet the needs of professionals in those establishments. The company has been producing the most important antibiotics and anesthetics sold to distributors and hospitals across the country.

Manufacturer usually replies in 2 days

aztreonam

Solution for injection 1g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Unavailable markets
Germany
Manufacturer #11630

Manufacturer usually replies in 4 days

aztreonam

Injection 250 mg, 500 mg, 1000 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

aztreonam

Injection 1000 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19203

Manufacturer usually replies in 6 days

aztreonam

Vials, injection 500mg, 1000mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Available for
Licensing with supply
Manufacturer #10323

Manufacturer usually replies in 5 days

aztreonam

Vials, injection 1000 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18204

Manufacturer usually replies in 9 days

aztreonam

Solution for injection/infusion 500 mg, 1000 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17147

Manufacturer usually replies in 7 days

aztreonam

Powder for solution for injection 0.5g, 1g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #16892

Manufacturer usually replies in 6 days

aztreonam

Vials, injection 1gm

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #16647
With more than 55 years of tradition in the preparation of medicinal specialties, the company research, develop, produce and market highly complex medicines. Quality, service, cutting-edge technology, and a firm professional development policy are the guidelines and commitments of the company’s history.

Manufacturer usually replies in 6 days

aztreonam

Vials, injection 1 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Available for
Licensing with supply, Distribution only
Manufacturer #18885

Manufacturer usually replies in 7 days

aztreonam

Solution for injection 1 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
IN
Unavailable markets
Pakistan
Available for
Licensing with supply, Distribution only
Manufacturer #8924

Manufacturer usually replies in 9 days

aztreonam

Injection 1 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20801

Manufacturer usually replies in 11 days

aztreonam

Injection 500 mg, 1000 mg, 2000 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19828

Manufacturer usually replies in 14 days

aztreonam

Vials, injection 1 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Colombia
GMP approvals
INVIMA
Manufacturer #18604
The company has more than 40 years of experience. in the development and commercialization of sterile drugs, with a presence in 22 Latin American countries, Asia and Africa. The mission of the company is to preserve health by supplying sterile drugs and pharmaceutical services that generate value for the community and its shareholders.

Manufacturer usually replies in 14 days

aztreonam

Injection 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20049

Want to view all 20 products? Create your free account today!

Aztreonam

Aztreonam is an antibiotic. It is prescribed primarily in the treatment of infections caused by gram-negative bacteria such as Pseudomonas aeruginosa which include bone infections, endometritis, intra-abdominal infections, urinary tract infections, pneumonia, and sepsis. Aztreonam is a manufactured version of a chemical from the bacterium Chromobacterium violaceum. Aztreonam’s nebulized forms are treat infections resulting from complications of cystic fibrosis in Europe and the US and used off-label to treat non-CF bronchiectasis, ventilator- associated pneumonia, COPD, mycobacterial disease, infections resulting from lung transplants. Aztreonam is sold under the brand names Azactam, and Cayston among others. The first patent was assigned to E. R. SQUIBB & SONS, INC in 1981 and later approved for sales in the United States in 1986. The World Health Organization calls it critically important for human medicine is now sold as a generic medication. It was removed from the WHO’s List of Essential Medicines in 2019.

Dosage Forms & Strengths

Aztreonam is recommended as an intravenous or intramuscular injection or inhaled through an ultrasonic nebulizer in the United States, after receiving approval from the FDA approved 2010, for the suppression of P. aeruginosa infections in patients with cystic fibrosis. It also got conditional approval in Canada and the EU in 2009 and has been fully approved in Australia. It is sold as a solution for inhalation in 75mg units and as a powder for injection in 1g and 2g units. In the treatment of Moderately severe systemic Infections, the dose is 1-2 g every 8 to 12hr with a max does cap at 8 g per day and for Severe or life-threatening, this dose is doubled at 2g given every 6 to 8 hours. For treating Pseudomonal Infections, the dose is 2 g every 6 to 8 hours, and for treating Urinary Tract Infections, it is 0.5 to 1 g every 8 to 12 hours. For treating Cystic fibrosis, the patient is given a 75 mg dose via nebulizer, every 8 hours for 28 days. The does should be at least 4 hr apart and should not exceed 28 days.

The Cost for Aztreonam

The in the USA, the consumers have to pay a cost of around $239 for a supply of 10 powder for injections of 1 g. The same 1g supply can be bought for less than USD 10 in India.

How does Aztreonam work?

Aztreonam actions are similar to penicillin as it inhibits synthesis of the bacterial cell wall. It does this by blocking peptidoglycan crosslinking. It has a mild affinity for penicillin-binding protein-1a and a high affinity for penicillin-binding protein-3. Its actions bind the penicillin- binding proteins of Gram-positive and anaerobic bacteria so it is not effective against other bacteria. Aztreonam is less bactericidal than some other cephalosporins. It has strong activity against susceptible Gram-negative bacteria, including Pseudomonas aeruginosa. It is resistant to some beta-lactamases and is inactivated by extended-spectrum beta- lactamases.

Finding Aztreonam Manufacturers and Suppliers:

The process of finding trusted Aztreonam manufacturers and Aztreonam suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B a marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. In addition, it is an easy to use online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of Aztreonam. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.